S K Pharma Machinery Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 17-11-2024
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 53.29 Cr
as on 17-11-2024
- Satisfied Charges ₹ 4.40 Cr
as on 17-11-2024
- Revenue 48.96%
(FY 2023)
- Profit -493.46%
(FY 2023)
- Ebitda -39.21%
(FY 2023)
- Net Worth -42.62%
(FY 2023)
- Total Assets 34.53%
(FY 2023)
About S K Pharma Machinery
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹53.29 Cr. The company has closed loans amounting to ₹4.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shailesh Panchal and Govind Panchal serve as directors at the Company.
- CIN/LLPIN
U29248MH2007PTC171255
- Company No.
171255
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2007
- Date of AGM
04 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at S K Pharma Machinery?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Panchal  | Director | 01-Jun-2007 | Current |
| Govind Panchal | Director | 01-Jun-2007 | Current |
Financial Performance of S K Pharma Machinery.
S K Pharma Machinery Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.96% increase. The company also saw a substantial fall in profitability, with a 493.46% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S K Pharma Machinery?
In 2023, S K Pharma Machinery had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mykro Fab Technologies Private LimitedActive 1 year 7 monthsShailesh Panchal and Govind Panchal are mutual person
- Ridz Infoline Private LimitedActive 2 years 6 months
Shailesh Panchal and Govind Panchal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tjsb Sahakari Bank Limited Creation Date: 22 Mar 2024 | ₹1.50 Cr | Open |
Tjsb Sahakari Bank Limited Creation Date: 21 Oct 2022 | ₹8.00 M | Open |
Tjsb Sahakari Bank Limited Creation Date: 21 Oct 2022 | ₹3.20 Cr | Open |
How Many Employees Work at S K Pharma Machinery?
S K Pharma Machinery has a workforce of 169 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S K Pharma Machinery, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S K Pharma Machinery's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
